Rene Haas, chief executive of Arm Holdings, one of the UK’s largest chip companies, has claimed that artificial intelligence (AI) will be able to find a cure for cancer “in our lifetime”. Haas stated that while modelling how a DNA marker is affected by cancer is currently “too complex” for humans or existing technology, computers are “going to solve it” in the future.
Haas, who previously served on the board of AstraZeneca, told the BBC that as more models are fed into computers and the machines become more sophisticated, they will overcome the current complexities. Scientists are already utilising AI-driven tools in cancer research and testing, with the NHS reporting that over 4 million patients received faster lung diagnoses earlier this year thanks to AI-powered X-ray tools.
The Arm Holdings CEO also suggested that AI would facilitate the widespread use of humanoid robots within the next five years. He noted that AI would enable these robots to see, learn, and be reprogrammed for various tasks, particularly in the service industry, though chip shortages are currently hindering growth in this area.